Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
769.450.1%
QQQ
717.500.2%
BTC/USD
79585.620.1123%
DIA
532.880.22%
GLD
406.530.06%
TLT
82.240.04%

AEON Biopharma Inc

AEONAMEX
Trade with Public
Trade with Public
$0.2408
-0.0139-5.46%
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareStock Report

AEON Biopharma Analyst Price Targets

Wall Street analyst price targets and consensus rating for AEON Biopharma (AEON).

Price Target Range — 5 Quarters

Analyst Consensus — 2 Analysts

2Buy
Consensus RatingBuy# Analysts2Avg. Consensus PT$4

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 14, 2026HC Wainwright & Co.Douglas TsaoPT CutBuy$5→$1
Oct 8, 2025Aegis CapitalDavid BoucheyMaintainedBuy$7
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on AEON Biopharma, Lowers Price Target to $1.2

HC Wainwright & Co. analyst Douglas Tsao maintains AEON Biopharma (AMEX:AEON) with a Buy and lowers the price target from $5 to $1.2.
Benzinga Newsdesk

PRO
Aegis Capital Reiterates Buy on AEON Biopharma, Maintains $7.2 Price Target

Aegis Capital analyst David Bouchey reiterates AEON Biopharma (AMEX:AEON) with a Buy and maintains $7.2 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on AEON Biopharma, Maintains $5 Price Target

HC Wainwright & Co. analyst Douglas Tsao reiterates AEON Biopharma (AMEX:AEON) with a Buy and maintains $5 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on AEON Biopharma, Lowers Price Target to $5

HC Wainwright & Co. analyst Douglas Tsao maintains AEON Biopharma (AMEX:AEON) with a Buy and lowers the price target from $6 to $5.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on AEON Biopharma, Maintains $6 Price Target

HC Wainwright & Co. analyst Douglas Tsao reiterates AEON Biopharma (AMEX:AEON) with a Buy and maintains $6 price target.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on AEON Biopharma, Maintains $6 Price Target

HC Wainwright & Co. analyst Douglas Tsao reiterates AEON Biopharma (AMEX:AEON) with a Buy and maintains $6 price target.
Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved